What contributes to successful transfection?

Cell line health and viability, nucleic acid quality, transfection reagents, duration of transfection, and serum requirements all affect the success of transfection. Cells must be healthy, uncontaminated, and in the correct growth phase and density (typically 40-80% confluent for chemical methods). Nucleic acid quality (high purity, low endotoxin levels) and appropriate reagent concentration are also crucial for optimal outcomes.

Is it possible to predict the transfectability of a specific type of cell?

No, predicting transfection efficiency based solely on cell type is not possible. The interactions between cell properties and transfection reagents are complex. However, it is empirically known that some cell types, such as primary cells, quiescent cells, and suspension cells, are generally difficult to transfect.

What impact does the type and quality of DNA or RNA have on transfection success?

High-purity genetic material consistently leads to better transfection outcomes. Endotoxin contamination, introduced during bacterial processing, must be removed as it can trigger the innate immune system and hinder transfection. Additionally, promoter characteristics, gene properties affecting cell physiology or survival, and the nucleic acid's size and structure all influence transfection success.

How is Transfection Different from Transformation and Transduction?

Transfection refers to the introduction of foreign nucleic acids into cells, typically by non-viral methods, especially in animal cells. Transformation describes the same process in plant, fungal, and bacterial cells, but is avoided in animal cell biology due to its association with 'malignant transformation' in cancer. Transduction refers to the viral-mediated transfer of nucleic acids into cells.

지역사회 공헌

해맑은 건강

코닝정밀소재는 2014년부터 지정기탁기부 사업을 진행하고 있습니다. 지정기탁 기부 사업이란 사회복지공동모금회에 기부한 금액을 활용하여 배분 지역, 당사자, 사용 용도를 기부자 명의로 지정할 수 있는 제도로, 임직원들이 매달 기부하는 해맑은 펀드와 추가 회사 부담금을 합해서 지원하고 있습니다. 코닝정밀소재는 지정기탁 기부 사업을 통해 루게릭병 환아를 위한 요양병원 건립 비용과 아프리카 심장 환아 수술비를 지원하였습니다.